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Abstract: 20!
Background 21!
Mild asthmatics who smoke cigarettes may develop unstable disease and neutrophilic 22!
infiltration of the airways, features more usually associated with severe asthmatic 23!
disease. The mechanisms giving rise to this response remain unclear. 24!
Objective 25!
To address the hypothesis that smoking increases bronchial mucosal production of 26!
IL-17A which acts on bronchial epithelial cells directly and in concert with other 27!
environmental stimuli to induce the production of IL-6 and neutrophil chemotaxins. 28!
Methods 29!
IL-17A, IL-8, IL-6, neutrophils and eosinophils was detected and quantified by 30!
immunohistochemistry in endobronchial biopsy sections from smoking and non-31!
smoking asthmatics. Human tracheal epithelial cells (HTEpC) were cultured with IL-32!
17A in the presence/absence of cigarette smoke extract (CSE) and aeroallergens 33!
lacking intrinsic protease activity, and IL-6 and IL-8 production measured in vitro. 34!
Results 35!
Expression of IL-17A, IL-6 and IL-8 and neutrophil numbers were significantly 36!
elevated in the bronchial mucosa of the asthmatic smokers compared to the non-37!
smokers. Expression of IL-17A correlated with that of IL-8 and neutrophil numbers. 38!
In the smoking asthmatics, eosinophil numbers also correlated with expression of IL-39!
8 and IL-17A. Exposure of HTEpC cells to both CSE and IL-17A increased 40!
expression of IL-6 and IL-8 in a concentration-dependent and synergistic manner. 41!
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Co-stimulation with CSE, IL-17A and aeroallergens further increased IL-6 and IL-8 42!
production synergistically. 43!
Conclusions  44!
The data support the hypothesis that asthmatic smokers develop neutrophilic 45!
inflammation of the airways propagated at least partly by smoke-induced production 46!
of IL-17A which together with smoke and other environmental stimuli acts on 47!
airways epithelial cells to induce neutrophil chemotaxins. 48!
  49!
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Abbreviations: 50!
COPD Chronic Obstructive Pulmonary Disease 51!
CSE Cigarette Smoke Extract 52!
ELISA Enzyme-linked immunosorbent assay 53!
FEV1 Forced expiratory volume in 1 second 54!
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 55!
HTEpC Human tracheal epithelial cells 56!
IHC Immunohistochemistry 57!
IL Interleukin 58!
IQR Interquartile range 59!
MBP Major Basic Protein 60!
NHS National Health Service 61!
OVA Ovalbumin 62!
PBS Phosphate-buffered saline 63!
PC20 Provocation concentration producing a 20% fall in forced expiratory 64!
volume in one second 65!
REC Research Ethics Committee 66!
ROS Reactive oxygen species 67!
SEM Standard error of the mean 68!
Th T helper 69!
TLR4 Toll-like receptor 4 70!71!
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INTRODUCTION 72!
Unfortunately, many asthmatics smoke cigarettes [1]. There is abundant evidence that 73!
smoking destabilises asthma [2, 3] and confers resistance to therapy [4, 5]. Smoking 74!
in asthma is accompanied by elevated inflammatory cellular infiltration of the 75!
airways, with a prominence of neutrophils [6, 7], a scenario associated with severe, 76!
difficult to control disease in non-smoking patients [8].  77!
Respiratory epithelial cells constitute the common environmental interface for 78!
cigarette smoke, pathogens and allergens in the respiratory tract and are able to 79!
respond to the latter through pattern recognition receptors independently of the IgE 80!
responses which characterise atopy [9]. There is nevertheless a paucity of research on 81!
the possible interactions between cigarette smoke and the airways mucosal epithelium 82!
which may drive neutrophilic inflammation in mild asthma. One notable possible link 83!
in this mechanistic chain is IL-17A, which has been described to stimulate various 84!
airways structural cells to produce CXC chemokines [10-12] which are produced in 85!
excess in the airways of patients with “neutrophilic” asthma [13]. Interestingly, IL-86!
17A production both in severe, non-smoking asthmatics [14] and in milder asthmatics 87!
who smoke [15] appears to be therapy resistant. Preliminary observations [16, 17] 88!
indicate that exposure of bronchial epithelial cells both to cigarette smoke and to IL-89!
17A increases their spontaneous release of CXCL8 (a key chemotactic factor for 90!
neutrophils as well as “primed” eosinophils [18]) and IL-6, an “acute phase” cytokine 91!
also associated with sputum neutrophilia in asthmatics [13, 19]. 92!
Consequently we constructed the present study to address the following hypotheses: 93!
(1) Cigarette smoking stimulates the production of IL-17A, neutrophil chemotaxins 94!
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and granulocytic infiltration within the bronchial mucosa of mild, corticosteroid naïve 95!
asthmatics; (2) Cigarette smoke extract and IL-17A enhance the production of pro-96!
neutrophilic cytokines by human airways epithelial cells both independently and 97!
synergistically; (3) This effect is further potentiated by non-antigen-specific (innate) 98!
interactions with environmental allergens. In order to address these hypotheses we 99!
quantified immunoreactive IL-17A+, IL-6+ and IL-8+ cells as well as elastase+ 100!
neutrophils and MBP+ (major basic protein) eosinophils in bronchial mucosal sections 101!
from corticosteroid naïve smoking and non-smoking asthmatics. We also examined 102!
the effects of IL-17A, alone and in combination with cigarette smoke extract (CSE) 103!
and environmental aeroallergens on the production of IL-6 and IL-8 by human 104!
airways epithelial cells ex vivo. 105!106!
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SUBJECTS, MATERIALS AND METHODS  107!
Subjects and fibreoptic bronchoscopy 108!
In view of the school of thought that corticosteroid therapy itself may be at least 109!
partly responsible for neutrophilic infiltration of the airways in asthma [20], we 110!
elected to perform a cross sectional comparison of mild, corticosteroid naïve 111!
asthmatic smokers and non-smokers (London Bridge Research Ethics Committee, 112!
REC approval reference 06/Q0704/175; Guy’s and St Thomas’ NHS Foundation 113!
Trust Research and Development Department, R&D approval number RJ1 07/0069). 114!
The following definitions were used when characterising participants: (i) asthma: a 115!
history of typical symptoms for ≥ 6 months prior to screening and histamine PC20 ≤8 116!
mg/ml; (ii) non-smoker: no smoking within 12 months of screening and < 0.5 pack 117!
year total history; (iii) smoker: currently smoking ≥ 5 cigarettes/week. The study was 118!
explorative and not formally powered because at the time inception of the study there 119!
were no suitable preliminary studies available to enable this. 120!
Informed consent was obtained from all subjects who then underwent a full 121!
assessment of their medical history, physical examination, St. George’s Respiratory 122!
Questionnaire, spirometry and measurement of histamine PC20. Fibreoptic 123!
bronchoscopy was performed in accordance with the British Thoracic Society 124!
guidelines [21]. Up to 12 endobronchial biopsies were obtained from the subcarinae 125!
of 3rd to 7th generation bronchi. 126!
Immunohistochemistry (IHC) 127!
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Cryostat sections (6 µm) were cut from biopsies prefixed in 4% paraformaldehyde 128!
(BDH Chemicals Ltd, Dagenham, UK), mounted on 0.1% poly-L-lysine-coated 129!
slides, dried overnight at 37°C then stored with silica gel (BDH Chemicals) at -80°C 130!
until used. Single IHC was performed as previously described [22] using the alkaline 131!
phosphatase anti-alkaline phosphatase (APAAP) technique with monoclonal 132!
antibodies against neutrophil elastase (NE, 1:100, Clone: NP57, Dako, Ely, UK) and 133!
eosinophil major basic protein (MBP, 1:30, Clone: BMK13, Abcam, Cambridge, 134!
UK), and polyclonal antibodies against IL-6 (1:500, Abcam), IL-8 (1:500, R&D 135!
Systems, Minneapolis, MN) and IL-17A (1:200, eBioscience, Hatfield, UK). Sections 136!
were then counterstained with Mayer’s haematoxylin solution (Sigma-Aldrich). 137!
Omission or substitution of the primary antibody with an irrelevant species- and 138!
isotype-matched immunoglobulin was used as a negative control. Stained cells in 139!
coded sections were counted by a single observer ignorant of their provenance in the 140!
entire area of the biopsy specimens with an Olympus BX40 microscope coupled with 141!
a Zeiss Vision KS300 imaging system (Carl Zeiss, Hamburg, Germany), which 142!
measured these areas and uniformised background pixilation automatically. 143!
Endobronchial biopsies from asthmatics have a tendency to lose some or all of their 144!
epithelium during the biopsy process and/or subsequent processing. In the present 145!
study, 6% of biopsies had a fully intact epithelium, 53% had a partially intact 146!
epithelium and 41% had no epithelium present. There was no statistical difference in 147!
the frequencies of these three outcomes in the biopsies from the non-smoking and 148!
smoking asthmatics (p = 0.4926). In view of this we elected to measure cell counts in 149!
the entire biopsy sections, which were expressed as the numbers of immunoreactive 150!
cells per unit area of the sections.   151!
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Cigarette smoke extract (CSE) preparation 152!
Cigarette smoke extract (CSE) was prepared based on a modification of the method of 153!
Carp and Janoff [23]. Two full-strength Marlboro cigarettes (filters removed; 154!
Marlboro Red, Class A cigarette, Tar 10 mg, Nicotine 0.8 mg; Phillip Morris USA, 155!
Richmond, VA) were combusted and the smoke bubbled through 50 ml of culture 156!
medium. To accomplish this, a 50 ml syringe (Becton Dickinson, Oxford, UK) was 157!
connected to a 3-way stopcock (Becton Dickinson). One of the other 2 arms of the 158!
stopcock was connected to a cigarette in a holder, and the final arm was connected to 159!
a glass Pasteur pipette (John Poulten, Barking, UK) submerged in a beaker containing 160!
culture medium. In a fume cupboard, each cigarette was lit and cigarette smoke drawn 161!
into the 50 ml syringe (to the 60 ml mark) over 10 seconds; following this the 162!
cigarette smoke was immediately bubbled into the culture medium over 2 to 3 163!
seconds. According to the protocol of Carp and Janoff [23], this solution was defined 164!
as “100% strength”. The resulting medium was then sterilised by passing through a 165!
0.20 µm filter (Sartorius, Epsom, UK), diluted to the required strength and used 166!
within 1 hour of preparation [23]. 167!
Human Airways Epithelial Cell Cultures 168!
Human tracheal epithelial cells from mixed healthy donors (HTEpC, PromoCell, 169!
Heidelberg, Germany) were cultured in accordance with the supplier’s instructions in 170!
bovine type I collagen coated 12 well tissue culture plates in Airway Epithelial Cell 171!
Medium which contained bovine pituitary extract 0.004 ml/ml, epidermal growth 172!
factor 10 ng/ml, insulin 5 µg/ml, triiodo-L-thyronine 6.7 ng/ml, holo-transferrin 10 173!
µg/ml, hydrocortisone 0.5 µg/ml, epinephrine 0.5 µg/ml and retinoic acid 0.1 ng/ml 174!
CIGARETTE SMOKING IN ASTHMATICS INCREASES IL-17A EXPRESSION!
! 10!
(PromoCell) and was supplemented with 1% antibiotic-antimycotic (Gibco, Paisley, 175!
UK). 24 hours prior to stimulation the culture medium was changed to a “starvation” 176!
medium (Airway Epithelial Cell Medium without hydrocortisone, epinephrine and 177!
retinoic acid supplemented with 1% antibiotic-antimycotic and 25 mM HEPES 178!
(Sigma-Aldrich)). The cells were then exposed for 24 hours to 0.1, 1.0 and 10 ng/ml 179!
of recombinant human IL-17A (PeproTech, London, UK), 0.16% CSE, 5000 SQ-180!
U/ml Felis domesticus Aquagen SQ (Alk-Abello, Horsholm, Denmark) and 5000 SQ-181!
U/ml Phleum pratense Aquagen SQ (Alk-Abello), then supernatants collected for 182!
analysis [24, 25]. The concentration  (0.16%) of CSE employed for these experiments 183!
was determined from prior concentration/response and time course studies to 184!
stimulate maximal cytokine production in HTEpC (data not shown). After removal of 185!
culture supernatant, cellular viability was assessed under light microscopy by trypan 186!
blue exclusion. The viability of HTEpC cells when exposed to CSE under these 187!
experimental conditions remained in excess of 90% throughput the culture period. 188!
ELISA 189!
Concentrations of IL-6, IL-8, IL-17A and IL-17F were measured in culture 190!
supernatants using commercial ELISA (PeproTech, London, UK) in accordance with 191!
the manufacturer’s instructions. 192!
Statistical Analysis 193!
Statistical analysis was performed using software embedded in Prism 5 for Mac OS X 194!
Version 5.0c (GraphPad Software Inc, La Jolla, CA). Data were summarised as the 195!
mean and standard error, or the median and interquartile range (IQR) as appropriate. 196!
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Data were compared following testing for deviance from a Gaussian distribution and 197!
for equality of variance using parametric analysis (parametric one-way analysis of 198!
variance, paired student’s t-test, linear regression, Pearson’s correlation) or non-199!
parametric analysis (Mann-Whitney U test, Kruskall–Wallis one-way analysis of 200!
variance) as appropriate.  Since the variances of the data from the asthmatic groups 201!
were not homogeneous, they were compared using non-parametric statistical analysis. 202!
Parametric statistical analysis was employed for all other comparisons since the data 203!
obtained satisfied the relevant statistical assumptions. In the IL-17A and CSE 204!
interaction experiments, synergistic interaction was defined as significant variation 205!
(using one-way analysis of variance) in the magnitude of CSE-induced cytokine 206!
expression in excess of spontaneous secretion at the concentrations of IL-17A tested. 207!
In the allergen, IL-17A and CSE interaction experiments, synergistic interaction was 208!
defined as a significant, further allergen-induced increase in the effects of IL-17A and 209!
CSE, either alone or in combination.  One-way analysis of variance (ANOVA) was 210!
performed on the magnitude of the IL-17A concentration series-induced increases on 211!
cytokine secretion from baseline in the additional presence of CSE. Statistical 212!
significance was taken as p<0.05. P values are quoted to two significant figures.  For 213!
Pearson’s correlations, r is the Pearson’s correlation coefficient while r2 is the 214!
coefficient of determination.  215!216!
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RESULTS 217!
Subject characteristics 218!
Endobronchial biopsies were obtained from 10 asthmatic non-smokers and 8 219!
asthmatic smokers (Table 1). All asthmatic smokers were current smokers with a 220!
median (IQR) pack year history of 4.7 (0.9 – 18.0) pack years, currently smoking 14.0 221!
(6.3 – 20.0) cigarettes per day. Of those classified as asthmatic non-smokers, 2 222!
subjects were ex-smokers. The ex-smokers had stopped smoking 3 and 14 years prior 223!
to the study, with pack year histories of 0.125 and 0.150 pack years. Asthma severity 224!
in the two asthmatic groups was equivalent, as defined by % predicted FEV1 (p = 225!
0.9355), FEV1/FVC ratio (p = 0.6856), PC20 histamine (p = 0.4543) and 226!
bronchodilator reversibility (p = 0.1609). All asthmatic subjects were using only 227!
intermittent short acting β2-agonist therapy for management of their asthma. 228!
Mucosal expression of pro-inflammatory cytokines (Figures 1 and 2) 229!
The median numbers of bronchial submucosal cells expressing immunoreactive IL-6, 230!
IL-8 and IL-17A were significantly elevated in the asthmatic smokers compared to 231!
the asthmatic non-smokers (p = 0.03, p = 0.0008, p = 0.04 respectively). 232!
Mucosal infiltration with neutrophils and eosinophils (Figures 1 and 2) 233!
The median number of neutrophils in the submucosa of the airways of the asthmatic 234!
smokers was significantly elevated compared with the asthmatic non-smokers (p = 235!
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0.019). In contrast there was only a trend for an increase in the median numbers of 236!
eosinophils in the mucosal sections from the asthmatic smokers compared to 237!
asthmatic non-smokers (p = 0.07). 238!
Correlations between pro-inflammatory cytokine expression and cellular 239!
inflammatory profile (Table 2) 240!
Neutrophil numbers correlated strongly with IL-17A+ cell numbers in the bronchial 241!
mucosa of both asthmatic non-smokers and smokers (r = 0.857, p = 0.002 and r = 242!
0.907, p = 0.002 respectively). The linear regression model accounted for 74% (non 243!
smoking asthmatics) and 82% (smoking asthmatics) of the variance in the number of 244!
neutrophils attributed to the number of IL-17A+ cells.  In addition, IL-17A+ cell 245!
numbers correlated with IL-8+ cell numbers in both asthmatic non-smokers and 246!
smokers (r = 0.636, p = 0.048 and r = 0.850, p = 0.008 respectively). The numbers of 247!
IL-8+ cells correlated with the numbers of neutrophils in the asthmatic non-smokers 248!
but not the asthmatic smokers (r = 0.735, p = 0.02 and r = 0.678, p = 0.06 249!
respectively). 250!
There were in addition strong correlations between the numbers of eosinophils and 251!
the numbers of IL-8+ and IL-17A+ cells in the asthmatic smokers (r = 0.800, p = 0.02 252!
and r = 0.863, p = 0.006 respectively), with the linear regression model accounting for 253!
64% and 74% respectively of the variance in the data. These correlations were not 254!
evident in the asthmatic non-smokers. 255!
Cigarette smoke extract does not induce ex-vivo expression of IL-17A and IL-256!
17F by respiratory epithelial cells (Figure 3) 257!
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The spontaneous expression of both IL-17A and IL-17F by HTEpC was low (3 to 258!
5pg/ml) and not altered in the presence of a concentration series of CSE . 259!
Cigarette smoke extract synergistically increases IL-17A-induced ex-vivo 260!
expression of IL-6 and IL-8 by human airways epithelial cells (Figure 4) 261!
IL-17A alone effected a concentration-dependent increase in spontaneous release of 262!
IL-6 and IL-8 by HTEpC (ANOVA p < 0.0001 and p < 0.0001 respectively). The 263!
additional presence of CSE further augmented both IL-6 and IL-8 production by these 264!
cells in a concentration related, synergistic manner (ANOVA p < 0.0001 and p = 265!
0.008 respectively).  266!
Aeroallergens increase the expression of IL-6 and IL-8 induced by co-stimulation 267!
of epithelial cells with cigarette smoke extract and interleukin-17A (Figure 5) 268!
Spontaneous secretion of IL-6 by cultured airways epithelial cells ex vivo was 269!
significantly elevated in the presence of 0.16% CSE, 10 ng/ml IL-17A and 270!
commercially available cat dander and Timothy grass pollen aeroallergen extracts (p 271!
= 0.009, 0.01, 0.006 and 0.004 respectively). The combination of CSE and IL-17A 272!
increased IL-6 production to a significantly greater degree than either agent alone. 273!
While neither aeroallergen significantly altered the effects of CSE or IL-17A alone 274!
(cat p = 0.06, 0.17; grass p = 0.27, 0.98 respectively), both further significantly 275!
increased IL-6 production by the combination (p = 0.0004, 0.008 respectively). 276!
Similarly, spontaneous secretion of IL-8 by the epithelial cells was significantly 277!
elevated in the presence of 0.16% CSE, 10 ng/ml IL-17A and the cat dander and 278!
Timothy grass pollen extracts (p = < 0.0001, 0.0002, 0.01 and 0.01 respectively). 279!
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Again, the combination of CSE and IL-17A increased IL-8 production to a 280!
significantly greater degree than either agent alone. Again, while neither aeroallergen 281!
significantly altered the effects of CSE or IL-17A alone (cat p = 0.9648, 0.2791; grass 282!
p = 0.1573, 0.1861 respectively), both further significantly increased IL-8 production 283!
by the combination (p = 0.03, 0.01 respectively). 284!285!
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DISCUSSION 286!
Here we report a number of novel observations pertaining to understanding the impact 287!
of cigarette smoking and other environmental influences on asthma. Our data are 288!
clearly compatible with the hypothesis that exposure of asthmatic patients to 289!
environmental cigarette smoke increases de novo airways mucosal expression of IL-290!
17A, which in turn acts on structural cells of the mucosa, in this case epithelial cells, 291!
to induce the release of granulocyte chemoattractants with resultant influx of 292!
neutrophils. Furthermore, we show that cigarette smoke may interact with 293!
environmental allergens in a non-antigen-specific (innate) manner to enhance this 294!
effect.  295!
Our data are consistent with those of a previous study [26] in which the authors 296!
reported elevated IL-17A expression in the bronchial mucosa of mild/moderate 297!
asthmatics to a degree which correlated with the numbers of neutrophils in induced 298!
sputum, although surprisingly not in the bronchial mucosa. The findings of our in 299!
vitro experiments are also consistent with a previous study [24] showing that IL-17A 300!
induced expression of IL-6 and CXCL8 in primary human airways epithelial cells. 301!
We have here extended these findings by demonstrating that CSE is able to augment 302!
the expression of both IL-6 and CXCL8 induced by IL-17A in a synergistic manner, 303!
implying that cigarette smoke exposure supports and augments IL-17A mediated 304!
inflammation of the airways. In a similar vein, Wiehler and Proud [27] have shown 305!
synergy between IL-17A and human rhinoviral infection of human airways epithelial 306!
cells in inducing the production of CXCL8. Our new data raise the intriguing 307!
possibility that inhaled aeroallergens may also interact with cigarette smoke at the 308!
airways epithelial barrier in a manner almost certainly independent of acquired 309!
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immunity and IgE production, further to augment the expression of IL-6 and CXCL8 310!
in the presence of IL-17A and CSE. We believe that this is the first time that 311!
synergistic interaction between IL-17A, cigarette smoke and allergen exposure to 312!
induce the expression of pro-inflammatory cytokines has been demonstrated in human 313!
airways epithelial cells. It is possible to speculate that differing combinations of 314!
environmental influences in different patients conspire to destabilise asthma control 315!
through such mechanisms. 316!
While in our study both neutrophilia and CXCL8 expression correlated with IL-17A 317!
expression in the bronchial mucosa of both the smoking and the non-smoking 318!
asthmatic patients, supporting the hypothesis that IL-17A drives CXCL8 expression 319!
in both smokers and non-smokers in vivo, CXCL8 expression correlated with 320!
neutrophilia only in the non-smoking asthmatic patients, suggesting that in smoking 321!
asthmatics IL-17A may induce additional granulocyte chemoattractants. These may 322!
include eosinophil, as well as neutrophil chemoattractants given that local IL-17A 323!
expression also correlated with eosinophil infiltration in the asthmatic smokers. 324!
Possible cellular sources of these chemoattractants other than bronchial epithelial 325!
cells include endothelial cells, fibroblasts and smooth muscle cells [10-12]. We did 326!
not attempt to identify the IL-17A immunoreactive cells in the asthmatic bronchial 327!
biopsies: although contemporary studies implicate Th17 T cells as a likely source, it 328!
should be noted that other leukocytes, including γδ and invariant NK T cells, innate 329!
lymphoid cells, mast cells and neutrophils are possible alternative sources. 330!
There is considerable circumstantial evidence that IL-17A expression and neutrophilic 331!
infiltration of the airways are implicated in the pathogenesis of “difficult to control” 332!
asthma, either spontaneous [8, 14] or as a result of smoking [15]. This evidence will 333!
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remain circumstantial until mechanisms are uncovered whereby products of 334!
granulocytes regulate bronchial hyperresponsiveness, the core pathophysiological 335!
abnormality in asthma governing disease severity and stability. Chronic obstructive 336!
pulmonary disease (COPD), characterised by severe, irreversible airways obstruction 337!
and caused predominantly by cigarette smoking, is also characterised by neutrophil 338!
infiltration and elevated IL-17A expression in the airways [26, 28]. In addition to any 339!
direct effects that neutrophil products may exert on bronchial hyperresponsiveness in 340!
asthma, animal surrogates of allergic inflammation also suggest that neutrophils may 341!
play a key role in the development of Th2 type inflammation in atopic dermatitis [29] 342!
and asthma [30]. 343!
Our study has limitations. Since data on the effects of smoking on asthmatic airways 344!
are so limited, we were obliged to make some arbitrary decisions when choosing and 345!
classifying the subjects. We arbitrarily defined a smoker as someone who currently 346!
smokes ≥ 5 cigarettes per week and a non-smoker as someone not having smoked for 347!
at least 12 months prior to screening and with a < 0.5 pack year history. We 348!
deliberately avoided setting a minimum pack year smoking history as an exposure 349!
criterion for inclusion in the smoking group as this might have admitted chronic, 350!
heavy smokers vulnerable to COPD. Similarly, because of the ongoing debate about 351!
the possible influence of corticosteroid anti-asthma medication on the numbers of 352!
neutrophils in the airways [20] we elected to study mild, corticosteroid naive 353!
asthmatics. Clearly, in similar studies, smoking history, disease severity and 354!
concomitant corticosteroid therapy of asthmatics will likely modify outcomes [31, 355!
32]. Another intrinsic limitation of the present study is the lack of a non-asthmatic, 356!
smoking control group, without which it is impossible to determine whether or not the 357!
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smoking-induced changes we observed in the bronchial mucosa of our asthmatic 358!
patients were attributable to smoking per se or a possible interaction between 359!
smoking and asthma. Previous studies on smokers with or without COPD have, 360!
however, clearly demonstrated that smoking per se fails to induce IL-17A expression 361!
in the bronchial mucosa of non-diseased control subjects [26, 28, 33] and that this 362!
finding is also reflected in peripheral blood T cells, strongly suggesting that these 363!
effects of smoking do indeed reflect an interaction between smoking and asthma [34]. 364!
Similarly, the properties of airways epithelial cells may, at least in theory, differ in 365!
asthmatics and non-asthmatics, and smoking and non-smoking donors. When the 366!
present study was performed, human tracheal, but not bronchial epithelial cells were 367!
obtainable commercially (from pooled healthy donors), so we used these as a 368!
surrogate. While similarities in the properties of these cells cannot be assumed with 369!
certainty, we are aware of no published evidence to the contrary. Finally, we have not 370!
addressed the mechanisms by which CSE, IL-17A and allergens influence the 371!
function of airways epithelial cells. Montalbano and colleagues have recently 372!
demonstrated [35] that both CSE and IL-17A independently increase the production 373!
of reactive oxygen species (ROS) by bronchial epithelial cells. In a similar vein, 374!
exposure of human bronchial epithelial cells to a variety of pollen aeroallergens has 375!
also been shown to increase the production of ROS [25]. We therefore speculate that 376!
one mechanism underlying these interacting effects on airways epithelial cells 377!
involves the generation of ROS. 378!
In summary, our data suggest that IL-17A is at least one key mediator driving the 379!
neutrophilic inflammation seen in asthmatic smokers, and that structural cells of the 380!
airways likely play an important role in its pathogenesis. Our data also highlight the 381!
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functional significance of the airways epithelium in integrating a variety of 382!
environmental influences which may cause such inflammation and influence asthma 383!
control.384!
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FIGURE LEGENDS 553!
Figure 1: Endobronchial Biopsy immunohistochemistry fast red staining 554!
Endobronchial biopsy sections were stained for IL-6, IL-8, IL-17A, NE and BMK 555!
using monoclonal/polyclonal antibodies and fast red staining. Immunoreactive cells 556!
are stained red.  557!
Figure 2: Numbers of IL-6, IL-8 and IL-17A immunoreactive cells and elastase+ 558!
neutrophils and MBP+ eosinophils in sections of bronchial biopsies 559!
! = Asthma Non-smoker; " = Asthma Ex-smoker; # = Asthma Smoker  560!
AN = Asthma Non-smoker and AS = Asthma Smoker.  561!
 * p < 0.05, *** p < 0.001, n.s. = not significant. 562!
Figure 3: Cigarette smoke extract does not induce ex-vivo expression of IL-17A 563!
and IL-17F by respiratory epithelial cells 564!
HTEpC were cultured with a concentration series of CSE. Spontaneous release of IL-565!
17A (a) and IL-17F (b) was low and not altered in the presence of CSE following 24 566!
hours (open bars) and 72 hours (filled bars) of culture. Mean, n = 2.  567!
Figure 4: Co-stimulation of HTEpC human respiratory epithelial cells with IL-568!
17A and cigarette smoke extract 569!
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HTEpC were cultured with a concentration series of IL-17A in the presence/absence 570!
of CSE. a) and c) CSE synergistically increased IL-17A-induced IL-6 and IL-8 571!
secretion (ANOVA p < 0.0001 and p = 0.0079 respectively).  b) and d) 572!
Concentration-dependent effect of IL-17A on IL-6 and IL-8 secretion in the presence 573!
of CSE (ANOVA p < 0.0001 and p = 0.0079 respectively). Dotted lines depict the 574!
mean increases in baseline expression of IL-6 and IL-8 following stimulation with 575!
CSE alone.  Paired t-test. * p < 0.05, ** p < 0.01, *** p < 0.001, Mean ± SD, n = 5 – 576!
8. 577!
Figure 5: Effect of cat dander and timothy grass pollen on co-stimulation of 578!
HTEpC with IL-17A and cigarette smoke extract 579!
Data are presented as the mean ± SD of 4 experiments. Paired t-test.  * p < 0.05, ** p 580!
< 0.01, *** p < 0.001, **** p < 0.0001.  581!
  582!
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Table 1: Characteristics of the populations studied 583!
Characteristics 
Asthma  
Non smoker  
Asthma 
Smoker  
No. 10 8 
Age, yr 
27 
(24 – 32) 
22 
(18 – 36) 
Height, m 
1.77 
(1.64 – 1.84) 
1.79 
(1.60 – 1.92) 
Weight, kg 
72.6 
(66.5 – 81.8) 
87.3 
(68.9 – 101.5) 
Male/Female 6/4 6/2 
Never smoker / ex-smoker / 
current smoker 
8/2/0 0/0/8 
Pack-years * 0.125, 0.150 
4.7 
(0.9 – 18.0)  
Atopy, No. (%) 
10/10 
(100) 
8/8 
(100) 
PC20 histamine, mg/ml 
0.809 
(0.440 – 2.01) 
1.021 
(0.744 – 2.89) 
FEV1, % predicted 
93.7 
(80.7 – 107.9) 
91.4 
(78.3 – 112.5) 
Pre-bronchodilator FEV1/FVC, % 
77.6 
(65.9 – 83.1) 
79.3 
(69.9 – 84.3) 
Bronchodilator response, % 
7.5 
(3.4 – 14.9) 
9.5 
(9.0 – 18.9) 
St. George’s Respiratory 
Questionnaire Score 
13.48!!(4.47!– 19.54) 15.59!(9.29!– 21.03)! 
† p < 0.05 compared with asthma non smoker. Mann-Whitney test, Median and IQR. 584!
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* Two subjects in the asthma non-smoker groups were ex-smokers; pack year 585!
histories for these subjects are presented individually.  586!
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Table 2: Correlations between pro-inflammatory cytokine expression and 587!
cellular inflammatory profile in sections of bronchial biopsies from asthma non-588!
smokers and asthma smokers 589!
 Asthma non-smoker Asthma smoker 
Correlation NE+ MBP+ IL-17A+ NE+ MBP+ IL-17A+ 
IL-8+ 
0.735† 
(0.541) 
0.564 
(0.318) 
0.636† 
(0.405) 
0.678 
(0.460) 
0.800† 
(0.639) 
0.850§ 
(0.722) 
IL-17A+ 0.857§ 
(0.735) 
0.373 
(0.139) 
… 0.907§ 
(0.822) 
0.863§ 
(0.744) 
… 
Pearson’s r values, r2 values in parenthesis, significant correlations in bold type. † p 590!
< 0.05; § p < 0.01. 591!
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Figure 1: Endobronchial Biopsy immunohistochemistry fast red staining  
Endobronchial biopsy sections were stained for IL-6, IL-8, IL-17A, NE and BMK using monoclonal/polyclonal 
antibodies and fast red staining. Immunoreactive cells are stained red.  
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Figure 2: Numbers of IL-6, IL-8 and IL-17A immunoreactive cells and elastase+ neutrophils and MBP+ 
eosinophils in sections of bronchial biopsies  
 
● = Asthma Non-smoker; ○ = Asthma Ex-smoker; ■ = Asthma Smoker  
AN = Asthma Non-smoker and AS = Asthma Smoker.  
* p < 0.05, *** p < 0.001, n.s. = not significant.  
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Figure 3: Cigarette smoke extract does not induce ex-vivo expression of IL-17A and IL-17F by respiratory 
epithelial cells  
 
HTEpC were cultured with a concentration series of CSE. Spontaneous release of IL-17A (a) and IL-17F (b) 
was low and not altered in the presence of CSE following 24 hours (open bars) and 72 hours (filled bars) of 
culture. Mean, n = 2.  
Figure 3  
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Figure 4: Co-stimulation of HTEpC human bronchial epithelial cells with IL-17A and cigarette smoke extract  
 
HTEpC were cultured with a concentration series of IL-17A in the presence/absence of CSE. a) and c) CSE 
synergistically increased IL-17A-induced IL-6 and IL-8 secretion (ANOVA p < 0.0001 and p = 0.0079 
respectively).  b) and d) Concentration-dependent effect of IL-17A on IL-6 and IL-8 secretion in the 
presence of CSE (ANOVA p < 0.0001 and p = 0.0079 respectively). Dotted lines depict the mean increases 
in baseline expression of IL-6 and IL-8 following stimulation with CSE alone.  Paired t-test. * p < 0.05, ** p 
< 0.01, *** p < 0.001, Mean ± SD, n = 5 – 8.  
Figure 4  
167x146mm (300 x 300 DPI)  
 
 
Page 39 of 40 Clinical & Experimental Allergy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 5: Effect of cat dander and timothy grass pollen on co-stimulation of HTEpC with IL-17A and cigarette 
smoke extract  
 
Data are presented as the mean ± SD of 4 experiments. Paired t-test.  * p < 0.05, ** p < 0.01, *** p < 
0.001, **** p < 0.0001.  
Figure 5  
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